GSK Investigational Site

Terrassa - Barcelona 08221

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Multiple Myeloma

Studies at this site

• Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma — Completed
• Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease — Running, not enrolling